Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria B Laursen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nucleic Acids Research|August 30, 2007
Improved silencing properties using small internally segmented interfering RNAsJesper B Bramsen, Maria B Laursen, Christian K Damgaard, et al.
Leukemia & Lymphoma|October 3, 2015
The application of human phase 0 microdosing trials: A systematic review and perspectivesPernille Svendsen, Tarec C El-Galaly, Karen Dybkær, et al.
Molecular Oncology|May 15, 2024
Exploring the molecular landscape of cancer of unknown primary: A comparative analysis with other metastatic cancersLaura Andersen, Ditte S Christensen, Asbjørn Kjær, et al.
Molecular Biosystems|June 23, 2010
Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in vitro and in vivoMaria B Laursen, Malgorzata M Pakula, Shan Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosisKaren Dybkær, Martin Bøgsted, Steffen Falgreen, et al.
Nucleic Acids Research|March 14, 2009
A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicityJesper B Bramsen, Maria B Laursen, Anne F Nielsen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nucleic Acids Research|August 30, 2007
Improved silencing properties using small internally segmented interfering RNAsJesper B Bramsen, Maria B Laursen, Christian K Damgaard, et al.
Leukemia & Lymphoma|October 3, 2015
The application of human phase 0 microdosing trials: A systematic review and perspectivesPernille Svendsen, Tarec C El-Galaly, Karen Dybkær, et al.
Molecular Oncology|May 15, 2024
Exploring the molecular landscape of cancer of unknown primary: A comparative analysis with other metastatic cancersLaura Andersen, Ditte S Christensen, Asbjørn Kjær, et al.
Molecular Biosystems|June 23, 2010
Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in vitro and in vivoMaria B Laursen, Malgorzata M Pakula, Shan Gao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosisKaren Dybkær, Martin Bøgsted, Steffen Falgreen, et al.
Nucleic Acids Research|March 14, 2009
A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicityJesper B Bramsen, Maria B Laursen, Anne F Nielsen, et al.
Pageof 1